Susquehanna International Group’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
BH
AC
VCM
RA
WCM
BAM
Susquehanna International Group's ANGO Position: Q1 2026 in Review
Susquehanna International Group reduced its AngioDynamics (ANGO) stake by 67% in Q1 2026, selling an estimated $460K and leaving 20,646 shares worth $235K. The position accounts for ﹤0.01% of the portfolio, ranked #11391.
Susquehanna International Group first reported a position in ANGO in Q2 2014 and has held it in 28 quarters since. The position peaked at $1.14M in Q4 2023. 147 funds tracked by Wall St. Rank hold ANGO as of Q1 2026.
- Susquehanna International Group held 20,646 shares of AngioDynamics worth $235K as of Q1 2026.
- Susquehanna International Group sold 42,485 AngioDynamics shares in Q1 2026, an estimated $460K.
- AngioDynamics made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #11391 holding.
- Susquehanna International Group first reported a position in AngioDynamics in Q2 2014 and has held it in 28 quarters since.
- Susquehanna International Group's AngioDynamics position peaked at $1.14M in Q4 2023.
- 147 funds tracked by Wall St. Rank held AngioDynamics as of Q1 2026.
Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.